Patients’ views of general practitioners’ provision of medicine information leaflets
Amber Young 1 2 , June Tordoff 1 , Sebastian Moore 1 , Alesha Smith 11 School of Pharmacy, University of Otago, PO Box 56, Dunedin 9054, New Zealand
2 Corresponding author. Email: amber.young@postgrad.otago.ac.nz
Journal of Primary Health Care 11(4) 359-366 https://doi.org/10.1071/HC19011
Published: 29 November 2019
Journal Compilation © Royal New Zealand College of General Practitioners 2019 This is an open access article licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
Abstract
INTRODUCTION: Giving patients medicine information leaflets with oral information could help improve patient understanding about their medicines. Some health professionals believe patients do not want to receive leaflets or find them too difficult to understand so do not provide them.
AIM: To investigate Dunedin general practitioners’ (GPs) provision of medicine information leaflets from patients’ reports and to examine patient views about the leaflets provided.
METHODS: Patients collecting prescriptions from community pharmacies in Dunedin, New Zealand, between December 2016 and February 2017 were asked to complete a survey. Responses were entered into SurveyMonkey and data were exported into Excel for analysis.
RESULTS: Of the 151 survey respondents, over three-quarters (79%) did not receive a medicine information leaflet from their GP in the last 6 months, although most believed it important to receive one. Many participants felt that leaflets improved their knowledge and helped them take their medication correctly. Most participants liked the leaflets they received, although over half (60%) would like a short summary leaflet. Patients did not commonly search for more information than their GP provided.
DISCUSSION: Some patients may not seek further information about their medicines other than during consultation. Although rarely given, most participants who received leaflets from their GP appreciated them. Most participants read and understood leaflets they were provided, although ready access to a one- to two-page summary leaflet may be preferable. Technology could enable GPs to easily provide leaflets to patients in their care.
KEYwords: Medicine information leaflet; patient communication; patient education; general practitioner.
References
[1] Young A, Tordoff J, Smith A. ‘What do patients want?’ Tailoring medicines information to meet patients’ needs. Res Social Adm Pharm. 2017; 13 1186–90.| ‘What do patients want?’ Tailoring medicines information to meet patients’ needs.Crossref | GoogleScholarGoogle Scholar | 27818214PubMed |
[2] Brounéus F, Macleod G, Maclennan K, et al. Drug safety awareness in New Zealand: public knowledge and preferred sources for information. J Prim Health Care. 2012; 4 288–93.
| Drug safety awareness in New Zealand: public knowledge and preferred sources for information.Crossref | GoogleScholarGoogle Scholar | 23205377PubMed |
[3] Shrank W, Avorn J, Rolon C, Shekelle P. Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review. Ann Pharmacother. 2007; 41 783–801.
| Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review.Crossref | GoogleScholarGoogle Scholar | 17426075PubMed |
[4] Raynor DK, Blenkinsopp A, Knapp P, et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. NIHR Health Technology Assessment programme: Executive Summaries. Southampton, UK: NIHR Journals Library; 2003-2007. [cited 2017 March 9]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK62252/
[5] Shrank WH, Avorn J. Educating patients about their medications: the potential and limitations of written drug information. Health Aff (Millwood). 2007; 26 731–40.
| Educating patients about their medications: the potential and limitations of written drug information.Crossref | GoogleScholarGoogle Scholar | 17485751PubMed |
[6] Raynor DK, Silcock J, Knapp P, Edmondson H. How do patients use medicine information leaflets in the UK? Int J Pharm Pract. 2007; 15 209–18.
| How do patients use medicine information leaflets in the UK?Crossref | GoogleScholarGoogle Scholar |
[7] Dixon-Woods M. Writing wrongs? An analysis of published discourses about the use of patient information leaflets. Soc Sci Med. 2001; 52 1417–32.
| Writing wrongs? An analysis of published discourses about the use of patient information leaflets.Crossref | GoogleScholarGoogle Scholar | 11286365PubMed |
[8] Koo MM, Krass I, Aslani P. Factors influencing consumer use of written drug information. Ann Pharmacother. 2003; 37 259–67.
| Factors influencing consumer use of written drug information.Crossref | GoogleScholarGoogle Scholar | 12549958PubMed |
[9] Aslani P, Hamrosi K, Feletto E. Investigating Consumer Medicine Information (CMI) Report. CMI Effectiveness Tender. Canberra: The Pharmacy Guild of Australia and Department of Health and Ageing; 2010.
[10] Harvey JL, Plumridge RJ. Comparative attitudes to verbal and written medication information among hospital outpatients. Ann Pharmacother. 1991; 25 925–8.
[11] McCray AT. Promoting health literacy. J Am Med Inform Assoc. 2005; 12 152–63.
| Promoting health literacy.Crossref | GoogleScholarGoogle Scholar | 15561782PubMed |
[12] Raynor DKT. Written information on medicines for patients: learning from the PIL. Drug Ther Bull. 2018; 56 145–49.
| Written information on medicines for patients: learning from the PIL.Crossref | GoogleScholarGoogle Scholar | 30470709PubMed |
[13] Young A, Tordoff J, Smith A. Regulatory agencies’ recommendations for medicine information leaflets: are they in line with research findings? Res Social Adm Pharm. 2018; 14 196–202.
| Regulatory agencies’ recommendations for medicine information leaflets: are they in line with research findings?Crossref | GoogleScholarGoogle Scholar | 28285793PubMed |
[14] Hamrosi KK, Raynor DK, Aslani P. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page? Res Social Adm Pharm. 2014; 10 656–68.
| Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page?Crossref | GoogleScholarGoogle Scholar | 24239213PubMed |
[15] Young A, Tordoff J, Leitch S, Smith A. Doctors and pharmacists provision and opinions of medicines information leaflets in New Zealand. Int J Clin Pharm. 2018; 40 676–85.
| Doctors and pharmacists provision and opinions of medicines information leaflets in New Zealand.Crossref | GoogleScholarGoogle Scholar | 29675683PubMed |
[16] Young A, Tordoff J, Leitch S, Smith A. Patient-focused medicines information: general practitioners’ and pharmacists’ views on websites and leaflets. Health Educ J. 2019; 78 340–51.
| Patient-focused medicines information: general practitioners’ and pharmacists’ views on websites and leaflets.Crossref | GoogleScholarGoogle Scholar |
[17] Liu LST, Goh BQ, Tang WP, et al. Drug information needs and concerns of primary care patients with newly prescribed chronic medications. Proc Singapore Healthc. 2018; 27 294–8.
| Drug information needs and concerns of primary care patients with newly prescribed chronic medications.Crossref | GoogleScholarGoogle Scholar |
[18] Mottram DR, Reed C. Comparative evaluation of patient information leaflets by pharmacists, doctors and the general public. J Clin Pharm Ther. 1997; 22 127–34.
| Comparative evaluation of patient information leaflets by pharmacists, doctors and the general public.Crossref | GoogleScholarGoogle Scholar | 9373811PubMed |
[19] Education counts. Educational attainment in the adult population. Wellington: Ministry of Education; 2019. [Cited 10 July 2019]. Available from: https://www.educationcounts.govt.nz/statistics/indicators/data/education-and-learning-outcomes/3680.
[20] Luk A, Tasker N, Raynor DKT, Aslani P. Written medicine information from English-speaking countries—how does it compare? Ann Pharmacother. 2010; 44 285–94.
| Written medicine information from English-speaking countries—how does it compare?Crossref | GoogleScholarGoogle Scholar | 20103613PubMed |
[21] Kummervold PE, Chronaki CE, Lausen B, et al. eHealth Trends in Europe 2005–2007: a population-based survey. J Med Internet Res. 2008; 10 e42
| eHealth Trends in Europe 2005–2007: a population-based survey.Crossref | GoogleScholarGoogle Scholar | 19017584PubMed |
[22] Treadgold P, Grant C. Patient Information Forum. Making the case for information: the evidence for investing in high quality health information for patients and the public. London: Patient Information Forum; 2013. [Cited 4 August 2018]. Available from: https://www.pifonline.org.uk/wp-content/uploads/2014/11/PiF-Case-for-Information-Report-Final-Full-Report.pdf
[23] Dickinson R, Hamrosi K, Knapp P, et al. Suits you? A qualitative study exploring preferences regarding the tailoring of consumer medicines information. Int J Pharm Pract. 2013; 21 207–15.
| Suits you? A qualitative study exploring preferences regarding the tailoring of consumer medicines information.Crossref | GoogleScholarGoogle Scholar | 23419082PubMed |
[24] Dickinson D, Raynor DT. Ask the patients - they may want to know more than you think. BMJ. 2003; 327 861
| Ask the patients - they may want to know more than you think.Crossref | GoogleScholarGoogle Scholar | 14551106PubMed |
[25] Hamrosi KK, Raynor DK, Aslani P. Pharmacist and general practitioner ambivalence about providing written medicine information to patients—A qualitative study. Res Social Adm Pharm. 2013; 9 517–30.
| Pharmacist and general practitioner ambivalence about providing written medicine information to patients—A qualitative study.Crossref | GoogleScholarGoogle Scholar | 23567071PubMed |
